Lupa Kata Sandi? Klik di Sini

atau Masuk melalui

Belum Memiliki Akun Daftar di Sini


atau Daftar melalui

Sudah Memiliki Akun Masuk di Sini

Konfirmasi Email

Kami telah mengirimkan link aktivasi melalui email ke rudihamdani@gmail.com.

Klik link aktivasi dan dapatkan akses membaca 2 artikel gratis non Laput di koran dan Majalah Tempo

Jika Anda tidak menerima email,
Kirimkan Lagi Sekarang

ASEAN Pharmaceutical Industry Exhibition to be Held in Jakarta

Translator

Editor

16 March 2017 21:26 WIB

TEMPO.CO, Jakarta - Jakarta International Expo Kemayoran will hold Southeast Asia's Convention on Pharmaceutical Ingredients of 2017 on March 22-24. The exhibition, which will mark its sixth event this year, is a venue for pharmaceutical industries, medicine suppliers, packaging, and health tools from across the globe to reach the Southeast Asian market.

Ivan Ferrari, the General Manager of PT UBM Pameran Niaga Indonesia and the event organizer of the exhibition, stated that Indonesia is one of Asia’s fastest growing pharmaceutical market. “Which is why we held the CPhl Southeast Asia as a trusted platform in order to broaden the network for local and international pharmaceutical industries,” Ferrari said on Thursday, March 16, 2017.

Ivan said that Indonesia’s pharmaceutical market average growth is 20.6 percent each year throughout 2011-2016. There are currently 239 pharmaceutical companies operating in Indonesia. Spread throughout a number of regions; 39 percent in West Java, 20 percent in East Java, and 15 percent in Jakarta.

Based on the data provided by the Investment Coordinating Board (BKPM), investments realizations at the fourth quarter of 2016 is dominated by basic chemical industries, chemical based products, and pharmacies are worth Rp 12.9 trillion. Meanwhile, foreign investments in the same segment reached US$ 0,7 billion.

General Manager for Quintiles IMS Indonesia, Wiwy Sasongko, stated that Indonesia's pharmaceutical industry is experiencing a positive growth throughout the last couple of years. This is proven by Indonesia’s achievement in becoming ASEAN’s largest pharmaceutical industry, which translates to roughly 27 percent of ASEAN’s total pharmaceutical industry.

RICHARD ANDIKA | NN



BPOM Reveals Indications of Drug Crimes in Indonesia's Pharmaceutical Industry

17 November 2022

BPOM Reveals Indications of Drug Crimes in Indonesia's Pharmaceutical Industry

According to the BPOM chief, the aspect of drug control in Indonesia is not strong enough.


BPOM Finds Alleged Counterfeit Raw Ingredients of Medicinal Syrup

9 November 2022

BPOM Finds Alleged Counterfeit Raw Ingredients of Medicinal Syrup

Food and Drug Monitoring Agency (BPOM) reports new findings after investigating the source of the raw material for the solvent of medicinal syrups.


BPOM: Pharmacy Industry Also Responsible for Drug Safety Assurance

27 Oktober 2022

BPOM: Pharmacy Industry Also Responsible for Drug Safety Assurance

BPOM head Penny Lukito says the drug quality and safety system is not only the sole responsibility of her agency but also the pharmaceutical industry.


MPR Speaker Calls an End on Healthcare's Import Dependency

8 Juni 2021

MPR Speaker Calls an End on Healthcare's Import Dependency

MPR speaker Bambang Soesatyo urged the government to stop being dependent on imported healthcare and medical equipment.


Jokowi Calls for Health System Reform

5 November 2020

Jokowi Calls for Health System Reform

President Jokowi said that 90 percent of drug and raw materials still rely on imports, which was considered wasting foreign exchange.


A Long and Winding Road

23 Oktober 2020

A Long and Winding Road

Not all of Indonesia's biodiversity has been exploited to make natural medicines. Government subsidies must not be the determining factor.


Erick Thohir Calls For Research on Coronavirus Vaccine

5 Februari 2020

Erick Thohir Calls For Research on Coronavirus Vaccine

SOE Minister Erick Thohir was encouraging the state pharmaceutical industry to conduct research aiming to find the vaccine against the coronavirus.


Dishonest Doctors

14 November 2019

Dishonest Doctors

Collusion between doctors and pharmaceutical companies over the sale of medicines still continues.


Industry Ministry Aims at Rp130tn Investments in Three Sectors

4 Januari 2019

Industry Ministry Aims at Rp130tn Investments in Three Sectors

The Industry Ministry projected investment values for the chemical, pharmaceutical, and textile industries (IKFT) would reach Rp130 trillion in 2019.


Indofarma Seeks to Cut Rp93bn in Costs

3 Desember 2014

Indofarma Seeks to Cut Rp93bn in Costs

In a bid to cut operational costs,the state-owned pharmaceutical

company has trimmed down its number of managers from 38 people

to just 18.